SUN Pharmaceutical Industries Limited Cefpodoxime Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Cefpodoxime Export Records India — #5 Exporter, 32 Shipments, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cefpodoxime

India Pharmaceutical Trade Intelligence

$79.5M178 Suppliers78 CountriesHS 30042019

ExportsIndia → UNITED STATES69.6%India → FRANCE5.8%

ImportsUNITED STATES → India$865 FRANCE → India$34

#1 Supplier: ALKEM LABORATORIES

SUN Pharmaceutical Industries Limited — Cefpodoxime Exporter #5 | $1.6M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Cefpodoxime Exporter Profile

Indian Pharmaceutical Exporter · #5 for Cefpodoxime · $1.6M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #5 Indian exporter of Cefpodoxime with $1.6M in export value and 32 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.0% market share in Cefpodoxime exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Cefpodoxime Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Cefpodoxime export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Cefpodoxime?

Country	Value	Shipments	Share
BELGIUM	$680.2K	20	60.1%
SOUTH AFRICA	$182.6K	5	16.1%
FRANCE	$169.7K	5	15.0%
UNITED ARAB EMIRATES	$100.0K	2	8.8%

Who Are the Top Buyers of Cefpodoxime from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$432.4K	14
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$155.1K	4
M/S. PLANET PHARMA	FRANCE	$100.0K	2
M S YUSEN LOGISTICS BENELUX BELGIU MKEETBERGLAAN	BELGIUM	$92.7K	2
RANBAXY SOUTH AFRICA PTY LIMITED	SOUTH AFRICA	$87.6K	2
MS PLANET PHARMA SAAU CAPITAL	FRANCE	$69.7K	3
MS GIGI MEDICAL STORE LLC	UNITED ARAB EMIRATES	$50.0K	1
M S RANBAXY SOUTH AFRICA PTY LIMITED	SOUTH AFRICA	$50.0K	1
M/S. GIGI MEDICAL STORE LLC ,	UNITED ARAB EMIRATES	$50.0K	1
M/S. RANBAXY PHARMACEUTICALS PTY LT	SOUTH AFRICA	$23.1K	1

SUN Pharmaceutical Industries Limited supplies Cefpodoxime to 11 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and M/S. PLANET PHARMA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cefpodoxime Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
CEFPO BASICS TABLETS 200MG PACK : 4X5 (S05) BATCH : DFF1684B, DFF1685A EACH FILMCOATED TAB CONTS: CEFPODOXIME PROXETIL	$146.6K	3
CEFPO BASICS TABLETS 200MG PACK : 3X5 BATCH : DFF1686A EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEFPODOXIM	$92.5K	3
CEPODEM TAB 200MG PACK:10s STRIP BATCH:3207007 EACH FILM COATED TAB CONTS.CEFPODOXIME PROXETIL USP EQ TO CEFPODOXIME 200	$69.7K	3
CEFPO BASICS TABLETS 200MG PACK : 2X5 STRIP BATCH : DFF0161A EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEFP	$58.5K	3
CEFPO BASICS TABLETS 200MG PACK : 4x5 S05 Batch : DFE2291B EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEF	$50.0K	1
CEPODEM TABLETS 200MG PACK: 10s Strip BATCH: DFE3221A EACH TABLET CONT.: CEFPODOXIME PROXETIL EQ. TO 200MG	$50.0K	1
CEPODEM TAB 200MG APCK:10S STRIP BATCH:DFE4530A DFE4531A EACH FILM COATED TAB CONTS. CEFPODOXIME PROXETIL USP EQ TO CEF	$50.0K	1
CEFPO BASICS TABLETS 200MG PACK: Box2x5sBATCH: DFE6009A EACH FILM COATED TABLETCONT.: CEFPODOXIME PROXETIL EQ. TO CEFP	$50.0K	1
CEFPO BASICS TABLETS 200MG PACK: 4x5 S05 BATCH: DFE6008BEACH FILM COATED TAB CONT.: CEFPODOXIME PROXETIL EQ. TO CEFPO	$50.0K	1
CEPODEM TAB 200MG PACK:10s STRIP BATCH:DFE6575A DFE6576A EACH FILM COATED TAB CONTS CEFPODOXIME PROXETIL USP EQ TO CEFP	$50.0K	1

SUN Pharmaceutical Industries Limited exports 22 distinct Cefpodoxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFPO BASICS TABLETS 200MG PACK : 4X5 (S05) BATCH : DFF1684B with 3 shipments worth $146.6K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cefpodoxime Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	LUPIN LIMITED	$10.6M	297	9	$35.7K
4	AUROBINDO PHARMA LIMITED	$4.5M	89	10	$50.0K
5	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$1.6M	32	4	$50.0K
1	ALKEM LABORATORIES LIMITED	$1.4M	29	5	$50.0K
7	MICRO LABS LIMITED	$696.4K	30	3	$23.2K

SUN Pharmaceutical Industries Limited ranks #5 among 178 Indian Cefpodoxime exporters. Average shipment value of $50.0K compared to the market average of $189.3K. The closest competitors by value are LUPIN LIMITED and AUROBINDO PHARMA LIMITED.

Which Indian Ports Ship Cefpodoxime Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	174	10.0%
SAHAR AIR	166	9.6%
JNPT/ NHAVA SHEVA SEA	133	7.7%
SAHAR AIR CARGO ACC (INBOM4)	128	7.4%
JNPT	88	5.1%
DELHI AIR	81	4.7%
HYDERABAD ICD	79	4.6%
DELHI AIR CARGO ACC (INDEL4)	78	4.5%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cefpodoxime Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cefpodoxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 32 individual customs records matching SUN Pharmaceutical Industries Limited exporting Cefpodoxime, covering 22 formulations to 4 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 78+ countries, 442+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cefpodoxime

Cefpodoxime

SUN Pharmaceutical Industries Limited — Cefpodoxime Exporter Profile

SUN Pharmaceutical Industries Limited — Cefpodoxime Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Cefpodoxime?

Who Are the Top Buyers of Cefpodoxime from SUN Pharmaceutical Industries Limited?

What Is India's Total Cefpodoxime Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Cefpodoxime Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Cefpodoxime Exporters?

What Cefpodoxime Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Cefpodoxime to Key Markets

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cefpodoxime Exporters?

Which Indian Ports Ship Cefpodoxime Exports?

Cefpodoxime — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cefpodoxime Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cefpodoxime Export Data from SUN Pharmaceutical Industries Limited

Cefpodoxime Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source